ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

This study has been suspended.
Study NCT00077493.   Last updated on December 21, 2007.   Information provided by MedImmune LLC
Please refer to this study by its ClinicalTrials.gov identifier: NCT00077493


Locations
United States, Maryland
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office    
      Bethesda, Maryland, United States, 20892-1182

Sponsors and Collaborators
MedImmune LLC
Cambridge Antibody Technology

Investigators
Principal Investigator:     Alan S. Wayne, MD     NCI - Pediatric Oncology Branch    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers